Pfizer
Pfizer is a global biopharmaceutical company that discovers, develops, manufactures, and markets prescription medicines and vaccines for a wide range of therapeutic areas including oncology, immunology, cardiology, and infectious diseases. It serves patients, healthcare providers, governments, and health systems worldwide, generating revenue primarily through the sale of patented and off-patent drugs and vaccines. The company also engages in research collaborations and licensing agreements with other biopharma and biotech firms.
- Revenue
- $1B+
- Employees
- 5,001+
- Founded
- 1849
- Headquarters
- New York City, United States of America
Pfizer customers on Arbolus
Customers who reviewed Pfizer
Seniority of Pfizer customers
The largest group of people who reviewed Pfizer holds Manager roles (50%), followed by C-Suite (40%) and Director (10%).
- Manager 50%
- C-Suite 40%
- Director 10%
Customers sample
Employer names and spend open in the full report, along with the other 8 customers.
What 11 Arbolus experts think of Pfizer
Overall sentiment: Positive
NPS feedback is predominantly positive, with the majority of scores ranging between 6 and 10, primarily driven by executive and clinical Users citing scale, R&D strength, and distribution reliability as key value drivers. Renewal intent among Influencers is generally favorable, though select Influencers report offboarding or uncertain renewal, often tied to pricing and market competition. Most experts are in the advanced implementation or pilot stages, reflecting ongoing institutional engagements and product evaluations. Main qualitative themes include recognition of Pfizer's large-scale infrastructure, scientific leadership, product availability, and concerns over complexity and cost.
Everything 11 customers told us about Pfizer.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
9 Net Promoter Score, from 11 scored reviews- Promoters 3
- Passives 6
- Detractors 2
Praised
- Global Scale and Reach
- Supply-Chain Reliability
- R&D Investment and Innovation
- Digital Patient Support
Criticised
- Portfolio and Patent-Expiration Risk
- Competitive Therapy Threats
- Pricing and Market Access Pressure
- Internal Complexity
What Pfizer customers say
Global Scale and Reach
“Pfizer's ability to reach a wide patient audience and deliver medicines worldwide is unmatched, making it a reliable partner for healthcare organizations needing broad supply.”
Supply-Chain Reliability
“I trust Pfizer due to its large-scale manufacturing and global distribution network, which ensures strong product availability across regions.”
R&D Investment and Innovation
“I value Pfizer for its deep commitment to research and development, with extensive investments supporting a robust therapy pipeline beyond its current commercial portfolio.”
Renewal intent
Plan to renew 50%Plan to renew, by seniority
- 100% 2 answers
- 0% 1 answer
- 0% 1 answer
- 8/10 Average score from customers who will renew
- 6/10 Average score from undecided customers
- 8/10 Average score from customers not renewing
Report
For people who use Pfizer
Do you use Pfizer at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 11 customers of Pfizer have already contributed
Takes a few minutes. Your identity stays anonymous.